Real-life efficacy and safety data of lorlatinib treatment in ROS-1–positive advanced non-small cell lung cancer: Turkish Oncology Group (TOG) study.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Sedat Biter, Ahmet Taner Sümbül, Serdar Karakaya, Orhun Akdogan, Ali Güren, Mehmet Cihan İcli̇, Mahmut Büyüksimsek, Engin Kut, Serkan Menekse, Serhat Sekmek, Ozde Melisa Celayir, Gizem Yıldırım, Mehmet Emin Kalender, Ferit Aslan, Hicran Anık, Sevgi Topcu, Hasan Çağrı Yıldırım, Salih Tunbekici, Umut Disel, Ismail Oguz Kara
Institutions: Cukurova University, Adana Hospital, Ankara Atatürk Eğitim ve Araştırma Hastanesi, Gazi University, Marmara University, Hacettepe University Hospital, Hacettepe University, Ankara Bilkent City Hospital, İstanbul Başakşehir Çam ve Sakura Şehir Hastanesi, Bursa City Hospital, Niğde Ömer Halisdemir Üniversitesi, Ege University, Acıbadem Adana Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410809110